| Model Number |
030412 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
|
| Date of Event |
05/04/2018
|
|
Type of Reportable Event
|
Death
|
|
Additional Manufacturer Narrative
|
|
Concomitant medical products: unknown ligasur; 030454 030454 endo gia r/or 45 2.5mm; 030412 030412 endo gia uni 60 2.5 dlu x6; 030454 030454 endo gia r/or 45 2.5mm; unknown endo gi unknown endo gia instrument (b)(4).Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
| |
|
Event or Problem Description
|
|
According to the literature, a retrospective study evaluated the efficacy and safety of parenchymal transection by the vessel sealing device compared with the stapler technique in patients who underwent open elective hepatic resection between november 2011 and july 2014.There were a total of 138 patients: there are 69 patients in the stapler hepatectomy group.In the stapler group, universal staple with 60millimeter (mm) reload with 2.5mm staples were used for parenchymal division.Complications included: 6 deaths.Cause of death was not reported.Article: randomized clinical trial of stapler hepatectomy versus ligasure¿ transection in elective hepatic resection author: j.Fritzmann year:2018 publication: john wiley <(>&<)> sons ltd.
|
| |
|
Search Alerts/Recalls
|